IRVINE, Calif.--(BUSINESS WIRE)--NeurOptics, the worldwide leader in the science of pupillometry, today announced the U.S. launch of its NPi ®-300, a next-generation automated pupillometer that ...

Automated pupillometry and the Neurological Pupil index™ (NPi®) emerge as critical tools for assessing patients at risk of brain injury across a broad spectrum of diagnoses IRVINE, Calif.--(BUSINESS ...

NeurOptics' NPi®-300, a next-generation pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, is now available globally in 15 countries. NPi-300 Pupillometer & the ...

NPi-300 Pupillometer and the Neurological Pupil index™ (NPi®) represent the gold standard in automated pupillary assessment for patients at risk of brain injury NeurOptics, the worldwide leader in the ...

The NPi Pupillometer supports neurological examination in adult and pediatric patients across a broad spectrum of diagnoses, including traumatic brain injury, stroke, seizure, or other neurological ...

The NeurOptics NPi Pupillometer has been included in more than 120 clinical studies, adopted in over 650 hospitals in the U.S., and is represented in more than 35 countries worldwide. NeurOptics® is ...

NeurOptics® is the leader in the science of pupillometry and NPi®. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technologies facilitating ...

NeurOptics, the worldwide leader in the science of pupillometry, today announced the U.S. launch of its NPi (R) -300, a next-generation automated pupillometer that enhances pupillary assessment to ...